NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Reconnect Labs

Reconnect Labs

Private
ZurichHealthcare & Life Scienceshttps://reconnect-labs.com/

Last Round

Series A

Aug 20, 2025

Total Funding Raised

$24.64M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Reconnect Labs is a biopharmaceutical company developing precision therapeutics and predictive diagnostics for sleep, anxiety, and substance use disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Mental Health, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Application

Keywords

psychedelic pharmaneuropsychiatric drug developmentpsychedelic biotechprecision psychiatryclinical-stage biopharmamental health therapeuticsAI drug discoveryshort-acting psychedelicsDMT therapycompanion diagnostics5-MeO-DMTdigital psychiatryinsomnia treatmentchronic pain treatmentanxiety treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Reconnect Labs Comparables

Compare Reconnect Labs with similar companies based on industry and business-model similarity.

Reconnect Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Reunion Neuroscience Inc.
81%
Gilgamesh Pharmaceuticals
79%
GH Research
79%

Reconnect Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 20, 2025
GrantAug 20, 2025
SeedMay 21, 2021

Key People

Founding team and executive leadership

Davor Kosanic

CEO & Co-founder

Founding Team

Reconnect Labs Investors

Notable investors and investment history

Reconnect Labs investors
InvestorRounds
Lionheart VenturesSeries A, Seed
re.Mind CapitalSeed
Apeiron Investment GroupSeed
EsperanteSeries A, Seed
Negev CapitalSeries A, Seed
Noetic FundSeries A, Seed
InnosuisseGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors increased 134% MoM, reaching 2.6K.

  • Aug 20, 2025

    $11.2M grant received from Innosuisse.

Reconnect Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Reconnect Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Reconnect Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersZurich
Employee Range9
Year Founded2021
Last FundingAug 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.